EUVIMEDEUVIMED entdecken
Crossref

Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury

Haoran Jia, Xilei Liu, Yiyao Cao, Hanhong Niu, Lan Zhang, RuiJun Li, Fanjian Li, Dongdong Sun, Mingming Shi, Liang Wa, Xiao Liu, Guili Yang und 3 weitere

Brain Research · 2023

DOI: 10.1016/j.brainres.2023.148383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2023. Verfasst von Haoran Jia und 14 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Repair and Regeneration in Central Nervous System, Tianjin, China; Department of N…. Hauptthemen laut MEDLINE: Ferroptosis, Brain Injuries, Traumatic. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI) is an important reason of neurological damage and has high morbidity and mortality rates. The secondary damage caused by TBI leads to a poor clinical prognosis. According to the literature, TBI leads to ferrous iron aggregation at the site of trauma and may be a key factor in secondary injury. Deferoxamine (DFO), which is an iron chelator, has been shown to inhibit neuron degeneration; however, the role of DFO in TBI is unclear. The purpose of this study was to explore whether DFO can ameliorate TBI by inhibiting ferroptosis and neuroinflammation. Here, our findings suggest that DFO can reduce the accumulation of iron, lipid peroxides, and reactive oxygen species (ROS) and modulate the expression of ferroptosis-related indicators. Moreover, DFO may reduce NLRP3 activation via the ROS/NF-κB pathway, modulate microglial polarization, reduce neutrophil and macrophage infiltration, and inhibit the release of inflammatory factors after TBI. Additionally, DFO may reduce the activation of neurotoxic responsive astrocytes. Finally, we demonstrated that DFO can protect motor memory function, reduce edema and improve peripheral blood perfusion at the site of trauma in mice with TBI, as shown by behavioral experiments such as the Morris water maze test, cortical blood perfusion assessment and animal MRI. In conclusion, DFO ameliorates TBI by reducing iron accumulation to alleviate ferroptosis and neuroinflammation, and these findings provide a new therapeutic perspective for TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBrain Injuries, TraumaticMiceAnimalsDeferoxamineNeuroinflammatory DiseasesReactive Oxygen SpeciesIron

Stichwörter der Autor:innen

DeferoxamineFerroptosisNLRP3 inflammasomeNeuroinflammationReactive oxygen speciesTraumatic brain injury

Substanzen

DeferoxamineReactive Oxygen SpeciesIron

Autor:innen und Institutionen

  • Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Repair and Regeneration in Central Nervous System, Tianjin, China; Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, Chi…
  • Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Repair and Regeneration in Central Nervous System, Tianjin, China; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
  • Graduate School, Tianjin Medical University, Tianjin, China; Department of Radiotherapy, Tianjin Medical University General Hospital, Tianjin, China.
  • Graduate School, Tianjin Medical University, Tianjin, China; Institute of Tianjin Geriatrics, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin City

Zitieren

APA

Jia, H., Liu, X., Cao, Y., Niu, H., Lan Zhang, Li, R., Li, F., Sun, D., Shi, M., Wa, L., Liu, X., Yang, G., Chen, F., Zhang, S., & Zhang, J. (2023). Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. Brain Research. https://doi.org/10.1016/j.brainres.2023.148383

Vancouver

Jia H, Liu X, Cao Y, Niu H, Lan Zhang, Li R, et al. Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. Brain Research. 2023. doi:10.1016/j.brainres.2023.148383

BibTeX
@article{Jia2023,
  author = {Jia, Haoran and Liu, Xilei and Cao, Yiyao and Niu, Hanhong and Lan Zhang and Li, RuiJun and Li, Fanjian and Sun, Dongdong and Shi, Mingming and Wa, Liang and Liu, Xiao and Yang, Guili and Chen, Fanglian and Zhang, Shu and Zhang, Jianning},
  title = {Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury},
  journal = {Brain Research},
  year = {2023},
  doi = {10.1016/j.brainres.2023.148383}
}
Kostenlos starten →